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Genetic Epidemiologic Approaches to 
Understanding of Comorbidity of Substance 
Abuse and Psychiatric Disorders
Kathleen Ries Merikangas, Ph.D. 
Senior Investigator
Section on Developmental Genetic Epidemiology
In recognition of the scientific 
contributions of Samuel B. Guze 
 Emphasis on empiricism in psychiatry
 Validation of criteria for psychiatric disorders 
(Robins E. & Guze, S.  Am J Psychiatry, 1970)
 Application of family studies to investigate 
subtypes and overlap between syndromes
 Integration of clinical work and research
Goals 
 Population-based data on comorbidity
 Familial patterns of co-aggregation to 
illustrate genetic epidemiologic approach
 Patterns of co-occurrence and order of 
onset among high risk youth
 Clinical and research implications
Diseases with Greatest Global Burden : 
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World Health Organization, 2002
Patterns of Comorbidity in the Community
Guze SB Psychiatr Clin North Am. 1990 
Dec;13(4):651-9.
Secondary depression: observations in alcoholism, 
Briquet's syndrome, anxiety disorder, schizophrenia, 
and antisocial personality. A form of comorbidity?
Alc Abuse 3.8 4.7
Alc Dep 1.9 3.8
Drug Abuse   1.8 1.4
Drug Dep 0.7 0.6
Any Sub Abuse 9.4 9.4
Site NCS-R NES
12-month Prevalence of Substance Use Disorders 
in National Surveys of United States
NCS = National Comorbidity Survey Replication, Kessler et al; 1st 5000 cases
NES = National Epidemiologic Survey on Alcohol and Related Conditions, Grant et al
Comorbidity of Alcoholism and Mood 
Disorders in Community Studies
Author (yr) Subtype Alc Abuse Alc Dep
Brady (92) BPI 3.0 5.5
BPII 3.9 3.1
MDD 0.9 1.6
Kessler (90) Mania 0.3 9.7
MDE 1.0 2.7
Grant (04) Mania 1.4 5.7
Hypomania 1.7 5.2
MDE 1.2 3.7
Comorbidity of Alcoholism and Anxiety 
Disorders in Community Studies
Author (yr) Subtype Alc Abuse Alc Dep
Brady (92) BPI 3.0 5.5
BPII 3.9 3.1
MDD 0.9 1.6
Kessler (90) Mania 0.3 9.7
MDE 1.0 2.7
Grant (04) Mania 1.4 5.7
Hypom 1.7 5.2
MDE 1.2 3.7
Mood 2.2 3.1 3.5
Anxiety 1.9 2.5 4.0
Behavior 3.3 5.7 5.6
(Median Odds Ratio)
Drug
Use Problems Dependence
International Consortium in Psychiatric Epidemiology:
Comorbidity of Drug and Psychiatric 
Disorders across Sites
Substance Abuse/Dependence Lifetime 
Comorbidity in Puerto Rican in San Juan 
and New Haven
Affective Dx Anxiety Dx
Alcohol
New Haven 40 % 38 %
San Juan 42 % 42 %
Drug
New Haven 48 % 49 %
San Juan 40 % 44 %
Guze SB. Semin Psychiatry. 1970 Nov;2(4):392-402. 
The role of follow-up studies: their contribution to 
diagnostic classification as applied to hysteria.
Prospective Studies 
Zurich Cohort Study of Young Adults
 Sample from general community of 
Zurich, Switzerland 
 Methods:
 Diagnostic interview for psychiatric and 
somatic disorders
 Comprehensive assessment of risk 
factors and correlates
 Evaluation of spectrum of expression of 
mental disorders in the community
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Statistical Methods
 Regression models were fit using generalized 
ordinal logistic models that yield an odds ratio 
for each cut-point in the ordinal outcome 
(Stata).
 The odds ratios represent the relative odds of 
being above the cut-point (e.g., alcohol abuse or 
dependence vs. none or use; and alcohol 
dependence vs. none, use, or abuse).
 These cut-points may be regarded as diagnostic 
thresholds.
Mood Disorders as Predictors of Alcohol 
Abuse/Dependence
ALCOHOL
Abuse Dependence 
Odds Ratio (CI)
Major Dep 1.3  (0.6,2.9) 2.2  (0.7,  7.2)
Manic Sx 2.4  (1.2, 4.8) 4.4  (1.5,12.7)
Bipolar II 9.1  (2.7,31.2) 21.0  (6.6,67.5)
Smoking as Predictor of Alcohol and 
Cannabis Abuse or Dependence
Alcohol
Abuse Dependence
Odds Ratio (CI)
ALCOHOL
6.3  (2.9,13.6) 7.6  (2.7, 21.7)
Smoking CANNABIS
8.6  (4.7,15.9) 40.4 (11.2,144.9)
Alcohol Use Disorders as Predictors of 
Cannabis Use/ Abuse/ Dependence
CANNABIS
Use Abuse/Dep 
Alcohol Odds Ratio (CI)
Abuse 1.7  (1.2, 4.1) 2.2  (0.7,6.9)
Dependence 3.8  (0.8, 4.1) 4.1  (1.0,15.8)
Results of Community Surveys
 Mood disorders are more strongly 
associated with alcohol dependence 
than with alcohol abuse
 The bipolar subtype has a significantly 
larger association with alcoholism 
than major depression
What are the potential explanations 
for comorbidity?
 Comorbidity is a marker of severity of the index 
disorder
 Different syndromes are developmentally 
different manifestations of the same underlying 
pathogenesis
 Comorbid disorder is a consequence of another 
index disorder, or vice versa
 Comorbid disorders are alternate manifestations 
of the same underlying familial liability
Sources of Comorbidity
Causal
Index Dx Comorbid Dx
Common Etiology
Index Dx
Risk Factors
Comorbid Dx
Guze SB, Cloninger CR, Martin RL, Clayton PJ.
Br J Psychiatry. 1986 Jul;149:17-23. 
A follow-up and family study of Briquet's syndrome.
Family Study of Explanations for 
Comorbidity
Mechanisms for Comorbidity:
Family Studies
Common Etiology
Increased risk of “comorbid” disorder 
alone among relatives of probands with 
index disorder
Causal (Precursor of Consequence)
Increased risk of “comorbid” disorder 
only in combination with same index 
disorder
Investigators: Yale Family Study of Comorbidity 
of Substance Disorders & Psychopathology
K.R. Merikangas S. Avenevoli
K. Conway L. Dierker
B. Fenton C. Grillon
J. Merikangas M. Preisig
N. Risch B. Rounsaville
D. Stevens M. Stolar
P. Szatmari H. Zhang
Yale Comorbidity Family Study : Sample
Probands ( N=262)
Drug Alcohol Anxiety Control
N of Probands 87      89 76        61
Sex (Males %) 58 71 26 43 
Age (Mean Yrs.) 36 40         40      41
N of Relatives 604 408 359 255
Relatives ( N = 1626)
What disorder runs in this family? 
III
II
I
BIPOLAR
ANXIETY
ALCOHOLISM
DEPRESSION
DRUG ABUSE
Probands
Substance Disorders in Relatives
Substance
Disorders
3.0
1.2
1.0
1.5
0.6
1.0
2.5
7.2
3.5
1.7  
2.3
Comorbidity in Relatives
Subst
MDD
Panic
ASP
Soc 
Phobia
Bipolar
Soc
Phobia
MDD
Bipolar
ASP
Panic
Mechanisms for Comorbidity:
Yale Family Study
Common Etiology
Panic, Major Depression & Substance Use 
Disorders have shared underlying etiologic factors.
Causal (Precursor of Consequence) 
The familial associations between Social Phobia, 
Bipolar Disorder & Behavior Disorders with 
Substance Use Disorders are independent, despite 
the high magnitude of comorbidity between them.
Common familial liability for
cannabis and alcohol dependence
Variable OR 95% CI
Latent Familial 8.4 1.2- 58.5
PROBANDS
Anxiety 0.7 0.4- 1.5
Depression 0.9 0.5- 1.7
Antisocial 0.4 0.1- 1.4
Alcohol Dep 2.6 1.2- 5.5
RELATIVES
Anxiety 1.5 0.9- 2.9
Alcohol Dep 4.3 2.0- 9.2
Antisocial 3.7 1.3-10.6
Yale High Risk Study: Age and Sex of 
Sample at Wave I
Sex 
(% male)
Age 
(% >12)
Substance 
+Anxiety
N=39
Normal
N = 57
Substance
N= 38
50.055.253.8
50.046.651.3
Proband Group
Anxiety
N=58
45.6
49.1
Total N = 203
Pathways to Substance Disorders through 
Psychopathology (Relative Risk)
Age
15 20 255 10
ADHD
Conduct
Conduct
Bipolar
6.0
5.0
4.0
5.0
Anxiety
Depression
2.0
Phobia
Use Abuse/Dependence
Alcohol
33%
6%
Nicotine
Cannabis       
/Other
0%
2%
32%
7% 10%
Alcohol
19%
Nicotine
19%
Cannabis 
/Other
7%
31%
7% 7%
10%
Overlap in Use and Abuse/Dependence on 
Specific Substances among Offspring
Alcohol
Prospective Association between Psychiatric 
and Substance Use Disorders by Ages 13-23 
(N=203)
Adjusted Risk Ratio
Substance
Pre-existing Dx Use    Abuse Dependence
Affective 0.6 1.7 3.2
Conduct 4.2 6.0 6.0
Oppositional 4.2 3.3 4.1
ADHD 0.9 2.0 3.6
Anxiety 0.9 1.9 5.5
ANY DX 1.3 3.0 5.7
Impact of  Parental History and 
Premorbid Psychopathology on 
Substance Use and Disorders
Attributable Risk
Use Disorder
Family History 20% 12%
Premorbid Disorder 20% 18%
BOTH 32% 20%
Summary
 Mood and anxiety disorders co-occur with 
alcohol and drug dependence in both clinical 
and community surveys
 Alcoholism is largely transmitted 
independently of most other comorbid 
considitions with the exception of panic and 
cannabis use disorder
 The onset of bipolar syndromes and social 
anxiety tend to precede that of alcohol 
problems. 
Implications
 Etiology: Identification of pathways and risk 
factors for the development of substance use 
disorders
 Treatment: Integration of psychiatric 
symptoms/syndromes in defining treatment 
strategies; Family-based approaches
 Prevention: Intervention in psychiatric 
syndromes may reduce incidence of substance 
use disorders; Offspring of substance abusers 
are important target for prevention
Clinic-based Prevention Opportunities
Offspring of parents in treatment 
for mental illness
Incorporation of potential sequelae 
of primary disorders in treatment 
(e.g., Geller, et al, 1998)
